Revolution Medicines, Inc.
RVMDW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 16 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $93.0M in total; no superinvestor holds it.
Other share classesRVMD
Holders of 5% or more of RVMDW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Revolution Medicines, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Revolution Medicines, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Revolution Medicines, Inc., newest first.
No Schedule 13D or 13G filings on Revolution Medicines, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Revolution Medicines, Inc. shares.
No Form 144 notices for Revolution Medicines, Inc. are on file.